BRTX
Biorestorative Therapies
$0.28
−$0.01 (−4.48%)Jul 27, 2026
Key metrics
The numbers that frame BRTX today
- Market cap
- $7.06M
- P/E (TTM)
- -0.6
- EV / FCF
- -0.3
- Gross margin
- 92.1%
- EV / Sales
- 11.0
- ROIC
- -3,005.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.16
- 52wk High
- $1.89
Growth
Revenue and earnings trend for BRTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BRTX
Is Biorestorative Therapies a good buy?
No. Biorestorative Therapies has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Biorestorative Therapies is selling at a very high price.
What is the market capitalization of BRTX?
Biorestorative Therapies's market capitalization is $7.06M.
What is the P/E ratio for BRTX stock?
Biorestorative Therapies's current P/E ratio is -0.6.
What is the 52-week high for BRTX stock?
The 52-week high for Biorestorative Therapies is $1.89. The current close of $0.28 is 85.3% below that high.
What is the 52-week low for BRTX stock?
The 52-week low for Biorestorative Therapies is $0.16. The current close of $0.28 is 74.2% above that low.
Does BRTX stock pay dividends?
Biorestorative Therapies does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BRTX?
Biorestorative Therapies's Debt / Equity ratio is 0.